Egan Dwight H

Chief Executive Officer, DirectorCo-Diagnostics, Inc. (CODX) · full profile →Form 4 · filed Nov 27, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 23, 2023Grant(A)151K$0317K
Nov 23, 2023Disposed to issuer(D)46K$1.26$58K271K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 23, 2023Option exercise(M)151K$0491K

Transaction Codes

A
Grant / award
D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-007921) within minutes of acceptance. Every field above traces to the original document. Verify it directly: